Hunan Hansen Pharmaceutical Co., Ltd.
2025 Annual Internal Control Evaluation Report
To All Shareholders of Hunan Hansen Pharmaceutical Co., Ltd.:
Based on the "Basic Norms for Enterprise Internal Control" and its supporting guidelines, as well as other internal control regulatory requirements (hereinafter referred to as the "Internal Control System"), and in conjunction with the company's internal control system and evaluation methods, we have evaluated the effectiveness of the company's internal control as of December 31, 2025 (the "Evaluation Date"), based on daily supervision and special supervision of internal control.
I. Important Statement
In accordance with the requirements of the Internal Control System, the establishment, improvement, and effective implementation of internal control, the evaluation of its effectiveness, and the truthful disclosure of the internal control evaluation report are the responsibilities of the company's Board of Directors. The Audit Committee supervises the establishment and implementation of internal control by the Board of Directors. The management is responsible for organizing and leading the daily operation of the company's internal control. The company's Board of Directors, Audit Committee, directors, and senior management guarantee that this report contains no false records, misleading statements, or major omissions, and they shall bear individual and joint legal responsibility for the truthfulness, accuracy, and completeness of the report.